2270879-07-5

2270879-07-5 structure
2270879-07-5 structure
  • Name: CHMFL-ABL-121
  • Chemical Name: CHMFL-ABL-121
  • CAS Number: 2270879-07-5
  • Molecular Formula: C30H31F3N6OS
  • Molecular Weight: 580.67
  • Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK Bcr-Abl
  • Create Date: 2019-07-01 07:06:15
  • Modify Date: 2025-08-25 18:14:57
  • CHMFL-ABL-121 is a highly potent type II ABL kinase inhibitor with IC50s of 2 nM and 0.2 nM against purified inactive ABL wt and T315I kinase protein, respectively[1].

Name CHMFL-ABL-121
Description CHMFL-ABL-121 is a highly potent type II ABL kinase inhibitor with IC50s of 2 nM and 0.2 nM against purified inactive ABL wt and T315I kinase protein, respectively[1].
Related Catalog
Target

ABL wt:2 nM (IC50)

In Vitro CHMFL-ABL-121 dose-dependently inhibits BCRABL's auto-phosphorylation at Y245 site in K562 (EC50 < 10 nM),MEG-01 (EC50 < 10 nM) and KU812 (EC50 < 30 nM) cells and also significantly blocks the phosphorylation of downstream signaling mediators STAT5, CrkL and ErK[1]. CHMFL-ABL-121 induces apoptosis and arrests cell cycle at G0/G1 phase[1].
References

[1]. Liu X, et al. Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia. Eur J Med Chem. 2018 Dec 5;160:61-81.

Molecular Formula C30H31F3N6OS
Molecular Weight 580.67
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.